Chia-Hua Kuo Selected Research

Caspase 9

9/2022	ZAKβ Alleviates Oxidized Low-density Lipoprotein (ox-LDL)-Induced Apoptosis and B-type Natriuretic Peptide (BNP) Upregulation in Cardiomyoblast.
4/2008	The coexistence of nocturnal sustained hypoxia and obesity additively increases cardiac apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chia-Hua Kuo Research Topics

Disease

23	Inflammation (Inflammations) 05/2024 - 12/2008
19	Hypertrophy 09/2022 - 05/2008
16	Hypoxia (Hypoxemia) 01/2022 - 08/2004
15	Cardiomegaly (Heart Hypertrophy) 01/2023 - 05/2008
15	Insulin Resistance 01/2020 - 11/2003
13	Fibrosis (Cirrhosis) 11/2022 - 10/2008
13	Body Weight (Weight, Body) 09/2021 - 10/2004
12	Neoplasms (Cancer) 12/2023 - 09/2009
9	Hypertension (High Blood Pressure) 12/2022 - 02/2014
9	Heart Failure 09/2022 - 04/2008
7	Heart Diseases (Heart Disease) 01/2023 - 02/2009
7	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2011
6	Ischemia 12/2023 - 05/2006
6	Hyperglycemia 03/2023 - 02/2004
6	Obesity 07/2021 - 04/2008
5	Lung Neoplasms (Lung Cancer) 12/2023 - 03/2011
5	Wounds and Injuries (Trauma) 12/2023 - 04/2011
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2013
5	Diabetes Mellitus 01/2021 - 02/2014
4	Cardiotoxicity 09/2023 - 01/2018
4	Diabetic Cardiomyopathies 05/2023 - 01/2011
4	Necrosis 03/2023 - 09/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2018 - 01/2013
4	Neoplasm Metastasis (Metastasis) 07/2014 - 03/2011
4	Brain Ischemia (Cerebral Ischemia) 01/2013 - 10/2010
3	Hemorrhagic Shock 12/2023 - 10/2012
3	Fatigue 01/2021 - 02/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 02/2010
3	Hyperlipidemias (Hyperlipidemia) 01/2018 - 02/2014
3	Muscular Atrophy (Muscle Atrophy) 01/2013 - 05/2006
2	Hyperpigmentation 05/2024 - 04/2021
2	Melanoma (Melanoma, Malignant) 05/2024 - 04/2021
2	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2023
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 09/2022
2	Myalgia 10/2022 - 01/2013
2	Rheumatoid Arthritis 10/2022 - 01/2022
2	Neuroblastoma 09/2022 - 08/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2021 - 03/2014

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2006
21	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2004
13	Insulin (Novolin)FDA Link 07/2021 - 02/2004
8	Angiotensin IIIBA 12/2022 - 01/2013
7	AntioxidantsIBA 08/2022 - 10/2014
6	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 02/2017
6	Phosphotransferases (Kinase)IBA 12/2021 - 10/2010
6	Atrial Natriuretic Factor (ANF)IBA 09/2021 - 05/2008
6	Sirtuin 1IBA 09/2021 - 01/2014
6	Streptozocin (Streptozotocin)FDA Link 09/2021 - 01/2011
6	Dehydroepiandrosterone (DHEA)IBA 08/2013 - 08/2006
5	Insulin-Like PeptidesIBA 12/2023 - 02/2009
5	IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA 09/2023 - 05/2008
5	Therapeutic UsesIBA 12/2022 - 02/2018
5	CollagenIBA 11/2022 - 02/2017
5	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2022 - 05/2008
5	Mitogen-Activated Protein KinasesIBA 02/2022 - 10/2010
5	FructoseIBA 06/2021 - 07/2008
5	Glucose Transporter Type 4IBA 01/2018 - 08/2004
5	Messenger RNA (mRNA)IBA 04/2017 - 11/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 08/2018
4	Estrogens (Estrogen)FDA Link 01/2023 - 02/2014
4	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2021 - 05/2008
4	CarbohydratesIBA 01/2021 - 02/2004
4	salicylhydroxamic acid (SHAM)IBA 01/2021 - 10/2010
4	Blood Glucose (Blood Sugar)IBA 01/2019 - 04/2011
4	GlycogenIBA 04/2012 - 08/2004
3	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2018
3	Gemcitabine FDA Link 12/2023 - 12/2022
3	CytokinesIBA 08/2023 - 08/2022
3	Caspase 3 (Caspase-3)IBA 09/2022 - 04/2008
3	Advanced Glycation End ProductsIBA 08/2022 - 08/2018
3	CalcineurinIBA 02/2022 - 12/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 02/2013
3	LigandsIBA 12/2021 - 03/2011
3	CalciumIBA 12/2021 - 07/2016
3	Hormones (Hormone)IBA 07/2021 - 10/2006
3	ResveratrolIBA 01/2021 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2017 - 10/2008
3	fas Receptor (CD95 Antigen)IBA 12/2016 - 04/2008
3	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 08/2015 - 06/2010
3	Growth Hormone (Somatotropin)IBA 04/2015 - 11/2003
3	Metformin (Glucophage)FDA LinkGeneric 02/2014 - 07/2008
3	Dehydroepiandrosterone SulfateIBA 08/2013 - 08/2006
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2013 - 10/2010
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 02/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 07/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2023 - 01/2022
2	Adenosine Triphosphate (ATP)IBA 12/2023 - 01/2022
2	Estrogen ReceptorsIBA 09/2023 - 12/2016
2	Transcription Factors (Transcription Factor)IBA 11/2022 - 05/2014
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022 - 01/2013
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2022 - 11/2017
2	Caspase 9IBA 09/2022 - 04/2008
2	EnzymesIBA 08/2022 - 04/2011
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 11/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 11/2018
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2021 - 05/2008
2	transcription factor NF-AT c3IBA 09/2021 - 10/2019

Therapy/Procedure

9	Therapeutics 05/2023 - 05/2010
3	Drug Therapy (Chemotherapy) 12/2023 - 07/2014
3	Transplantation 01/2022 - 11/2017